What If You Could Help ADHD Patients More Effectively?

What If You Could Help ADHD Patients More Effectively?

ADHD

Technology

Get Involved

Finally, a Clinically-Proven ADHD Solution

Finally, a Clinically-Proven ADHD Solution

Our Revolutionary ADHD Solution Showed

POSITIVE Effects in Sustained Attention!

Our ADHD Solution Showed POSITIVE Effects in Sustained Attention!

  Watch this video to see how Neeuro Partners with Samsung to Power Breakthrough ADHD Intervention!

This technological breakthrough has been proven effective in reducing Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Children:

✓ Help children manage their ADHD symptoms!
✓ Use a fun and interactive game to help solve their biggest issues with attention!
✓ Easily administer and track progress!

*The Technology is non-invasive and certified safe to use even for all ages!

OUR TECHNOLOGY HAS BEEN FEATURED ALL OVER INTERNATIONAL MEDIA:
OUR TECHNOLOGY HAS BEEN FEATURED ALL OVER INTERNATIONAL MEDIA:
“Our technology can accurately quantify a person’s attention level in real-time using a machine learning algorithm and, from there, develop a unique patented personalised training programme using a feed-forward concept for cognitive training. Further improvements have been made in recent iterations by capitalising on the latest deep learning approaches with our large dataset.”
Dr. Cuntai Guan, PhD

IEEE Fellow and Professor, Chief Scientist, Nanyang Technological University & Neeuro Pte Ltd

Instant Benefits To Your Clinical Practice

l

New Services

You can now offer new add-on services to your patients diagnosed with ADHD.

}

More Time

You’ll have more time to handle more patients and work with high value cases.

Better Quality

Monitor your patients remotely and touch-base with them more frequently.

Build Reputation

Use cutting-edge technology and be featured with Neeuro and its networks.

Concerned With The Growing Number of

Children Diagnosed with ADHD?

In fact, clinicians are concerned with the growing number of children diagnosed with ADHD worldwide! Attention is a real challenge for many children, even if they’re not diagnosed with attention challenges. Poor attention leads to poor memory, decision making and problem-solving, key functions when it comes to learning.

ADHD and Poor Focus

ADHD is a neurodevelopmental disorder that affects approximately two to 2 to 7% of children globally, with a growing number of cases in people aged 5 to 44 years worldwide.

Common symptoms represented by 38 to 57% of ADHD children include poor focus.

An epidemiological study of 20 countries from the World Health Organization found that across high-, upper–middle-, and low-/lower–middle-income countries, the mean worldwide prevalence of ADHD was ~2.2% overall in children and adolescents (aged <18 years).

The current management for ADHD includes medication and behavioural interventions where a clinician teaches both the parents and child strategies to reduce ADHD symptoms.

Clinical Trial Results

Neeuro’s Chief Scientist Cuntai Guan, who headed A*Star’s Biomedical Technology Research department, in collaboration with IMH and Duke-NUS, ran a clinical trial for Children with ADHD within the ages 6 to 12 years old.

Using a gamified intervention solution, “CogoLand”, the user concentrates/focus and the avatar in the game will move.

In the latest clinical trial that involved 172 ADHD children, the results showed that children who received 8 weeks of intervention showed more significant improvement in their inattentive symptoms than those who did not receive intervention.

Concerned With The Growing Number of Children Diagnosed with ADHD?

Clinicians are concerned with the growing number of children diagnosed with ADHD worldwide! Attention is a real challenge for many children, even if they’re not diagnosed with attention challenges. Poor attention leads to poor memory, decision making and problem-solving, key functions when it comes to learning.

ADHD and Poor Focus

ADHD is a neurodevelopmental disorder that affects approximately two to 2 to 7% of children globally, with a growing number of cases in people aged 5 to 44 years worldwide.

Common symptoms represented by 38 to 57% of ADHD children include poor focus.

An epidemiological study of 20 countries from the World Health Organization found that across high-, upper–middle-, and low-/lower–middle-income countries, the mean worldwide prevalence of ADHD was ~2.2% overall in children and adolescents (aged <18 years).

The current management for ADHD includes medication and behavioural interventions where a clinician teaches both the parents and child strategies to reduce ADHD symptoms.

Clinical Trial Results

Neeuro’s Chief Scientist Cuntai Guan, who headed A*Star’s Biomedical Technology Research department, in collaboration with IMH and Duke-NUS, ran a clinical trial for Children with ADHD within the ages 6 to 12 years old.

Using a gamified intervention solution, “CogoLand”, the user concentrates/focus and the avatar in the game will move.

In the latest clinical trial that involved 172 ADHD children, the results showed that children who received 8 weeks of intervention showed more significant improvement in their inattentive symptoms than those who did not receive intervention.

RECOGNIZED BY THESE AMAZING AWARDS:

Startup Category Winner in 2015

Best Innovative Startup in 2015

United Nations Champion for Regional Best Practice

Most Promising Startup

Top 200 Key Innovator in 2017

RECOGNIZED BY THESE AMAZING AWARDS:

Startup Category Winner in 2015

Best Innovative Startup in 2015

United Nations Champion for Regional Best Practice

Most Promising Startup

Top 200 Key Innovator in 2017

If You’re A Health Professional Looking for a NEW Solution To Help Parents Manage their Children’s ADHD, This is the Perfect Opportunity!

  • Clinically proven effective solution; 10 years in clinical trials.
  • Non-invasive and safe technology that helps children with ADHD to focus longer.
  • Breakthrough solution for parents who hesitate using medicines to treat children with ADHD.
  • Fun and engaging for children.

If You’re A Health Professional Looking for a NEW Solution To Help Parents Manage their Children’s ADHD, This is the Perfect Opportunity!

  • Clinically proven effective solution; 10 years in clinical trials.
  • Non-invasive and safe technology that helps children with ADHD to focus longer.
  • Breakthrough solution for parents who hesitate using medicines to treat children with ADHD.
  • Fun and engaging for children.
“At Neeuro, our aim is to utilise technology to enable positive change in the neurological agility and fitness of our users. We are privileged to be working with institutions such as the Institute of Mental Health, Duke-NUS (National University of Singapore) and A*STAR (Agency for Science, Technology and Research), in conjunction with our hardware partner Samsung, to explore the use of cutting-edge technology in order to achieve this aim.”
Dr. Alvin Chan, PhD

Chief Executive Officer & Co-Founder, Neeuro Pte Ltd

Introducing SenzeBand and CogoLand

Neeuro’s core products offer an advanced method of brain training and precision in-monitoring cognitive performance.

SenzeBand

SenzeBand is Neeuro’s non-invasive EEG headband that safely measures brain signals. Low-frequency signals on the forehead are picked up by four individual sensors, giving us four individual channels of brain signals.

The level of these frequencies reveals a user’s brain states. SenzeBand measures the user’s mental state in real-time.

This helps in accessing, training, and tracking cognitive skills and brain performance. It measures and tracks your attention, focus, mental workload and relaxation. And if you can measure it… you can improve it!

CogoLand

CogoLand is a digital intervention solution based on Brain Computing Interface (BCI) technology developed at A*STAR’s Institute for Infocomm Research (I2R), as a result of a collaboration between IMH and Duke-NUS Medical School in Singapore. Neeuro licensed the technology that created CogoLand and developed it into a commercial product, which consists of the SenzeBand headband to track brain signals as well as the CogoLand mobile application.

The aim of the game is to move a character through a maze. Unlike most games where users use a gamepad or touchscreen, the character’s movements can only be controlled by brainwaves. By keeping the mind focused on the character, the character moves forward. A loss of focus results in the character slowing down or remaining stationary. At higher levels, the user also needs to hit a button on the touchscreen to make the character jump while moving at the same time.

Patients will be required to pair the CogoLand mobile application with a Neeuro SenzeBand for the detection of brainwaves. Machine learning algorithms will capture and interpret the mental states of patients based on their brainwaves, and these subsequently drive various challenges within the game.

SenzeBand

SenzeBand is Neeuro’s non-invasive EEG headband that safely measures brain signals. Low-frequency signals on the forehead are picked up by four individual sensors, giving us four individual channels of brain signals.

The level of these frequencies reveals a user’s brain states. SenzeBand measures the user’s mental state in real-time.

This helps in accessing, training, and tracking cognitive skills and brain performance. It measures and tracks your attention, focus, mental workload and relaxation. And if you can measure it… you can improve it!

CogoLand

CogoLand is a digital intervention solution based on Brain Computing Interface (BCI) technology developed at A*STAR’s Institute for Infocomm Research (I2R), as a result of a collaboration between IMH and Duke-NUS Medical School in Singapore. Neeuro licensed the technology that created CogoLand and developed it into a commercial product, which consists of the SenzeBand headband to track brain signals as well as the CogoLand mobile application.

The aim of the game is to move a character through a maze. Unlike most games where users use a gamepad or touchscreen, the character’s movements can only be controlled by brainwaves. By keeping the mind focused on the character, the character moves forward. A loss of focus results in the character slowing down or remaining stationary. At higher levels, the user also needs to hit a button on the touchscreen to make the character jump while moving at the same time.

Patients will be required to pair the CogoLand mobile application with a Neeuro SenzeBand for the detection of brainwaves. Machine learning algorithms will capture and interpret the mental states of patients based on their brainwaves, and these subsequently drive various challenges within the game.

Progress Monitoring for CogoLand ADHD Solution

CogoLand consists of 24 sessions. The practitioner sits down with their patient and their parents to work on schedule for the 24 sessions:

  1. The child then takes a calibration assessment for the system to create a personalized model of his attention level.
  2. Once done, the child is all set to continue with the training sessions at the convenience of his home.
  3. Practitioners can track the child’s progress remotely.

Analyze Session Results

Academic Transfer Effect Training

Track Performance Over Time

Progress Monitoring for CogoLand ADHD Solution

CogoLand consists of 24 sessions. The practitioner sits down with their patient and their parents to work on schedule for the 24 sessions:

  1. The child then takes a calibration assessment for the system to create a personalized model of his attention level.
  2. Once done, the child is all set to continue with the training sessions at the convenience of his home.
  3. Practitioners can track the child’s progress remotely.

Analyze Session Results

Academic Transfer Effect Training

Track Performance Over Time

Hear From Our Partners Who Are Using The SenzeBand with Neeuro’s Products and Services!

“School-going children of all ages will definitely benefit from this brain programme, as it not only enhances their thinking capacity but provides an overall sense of confidence and achievement.”
Saras

Special Needs Education Specialist, Singapore

“Before, I did not know why the kids would behave in certain ways. It’s very hard to know how much they are learning. With Neeuro, I can tap into the kids’ mental state, to show how they are behaving while learning and performing their activities. This lets us target very accurately the point at which I can help the kid.”
Ms. Jeslyn Lim

Psychotherapist & Hypnotherapist, Mind Culture

“After the training, we definitely saw an impact. He was able to focus a lot better. Even his grades improved… NeeuroFIT makes learning definitely faster!”
Mrs. Anu Shankar

Parent, Chennai, India

Here’s How We’ll Get Started As Partners:

We’re Only Looking For A Handful Of Committed & Dedicated Medical Partners!

1. We get on a quick call to see if we’re the right fit for each other.

2. We’ll ask some questions, and answer yours as well until we’re both happy to move on. 🙂

3. A ‘Starter Pack’ will be sent, which includes a few SenzeBand sets and CogoLand. You also get all the following bonuses:

– Technical Support (Live Chat and 24/7 Direct Email Access)
– Enterprise Dashboard to manage your patients and easily show results to their parents.
– Full training provided to you and your team to ensure fast & easy adoption!

Discounted price NOW AVAILABLE to the first 5 partners!
Click here to reserve a slot.

Discounts AVAILABLE to the first 5 partners!
Tap here to reserve a slot.

IMPORTANT: Due to overwhelming response and requests by practitioners, slots are quickly running out. If you are interested in implementing an ADHD solution this year, contact us today!

The Team Behind Neeuro

Eddie Chau
Eddie Chau

Chairman & Founder

A serial entrepreneur who founded e-Cop, Brandtology, V-Key, with successful exits for both e-Cop and Brandtology.

Alvin Chan, PhD
Alvin Chan, PhD

Chief Executive Officer & Co-Founder

Formerly the Co-Founder and CTO of Brandtology (successfully exited and acquired by iSentia) with a background in computer security, big data, neural networks & artificial intelligence.

Calvin Wee
Calvin Wee

Chief Operating Officer

Regional Tech Sales and Marketing leader, with over 25 years of experience, leading teams across Asia in Apple, BlackBerry, JawBone, and ResMed.

Dr. Cuntai Guan, PhD
Dr. Cuntai Guan, PhD

Scientific Advisor

World-renowned scientist in brain-computer interface (BCI) research and a pioneer in medical applications using BCI.

Sudharshan T.
Sudharshan T.

Director, Business Development (India)

Develops growth sales strategies, tactics and action plans specializing in new business development and expansion in India.

This Is Why We Exist

Neeuro creates and develops innovations that empower people to live happier, healthier and more productive lives through the use of fun and effective learning methods. As a leading Digital Mental Health platform, we aim to utilise the technology to enable positive change in the ADHD healthcare sector.

Our therapeutic approach uses non-invasive brain computer interface (BCI) based games to treat children with ADHD symptoms. This patented solution was developed from over 10 years of research and clinical trials with various research institutes with an investment of over SGD $20 million / INR 100 crores. As each child may present with different ADHD related behaviours, it is important for parents to speak with a mental health professional to discuss the treatment options.

We believe that by offering these programs, you will be empowered to strengthen the areas that patients are weak and make sessions more enjoyable, meaningful and purposeful.

This Is Why We Exist

Neeuro creates and develops innovations that empower people to live happier, healthier and more productive lives through the use of fun and effective learning methods. As a leading Digital Mental Health platform, we aim to utilise the technology to enable positive change in the ADHD healthcare sector.

Our therapeutic approach uses non-invasive brain computer interface (BCI) based games to treat children with ADHD symptoms. This patented solution was developed from over 10 years of research and clinical trials with various research institutes with an investment of over SGD $20 million / INR 100 crores. As each child may present with different ADHD related behaviours, it is important for parents to speak with a mental health professional to discuss the treatment options.

We believe that by offering these programs, you will be empowered to strengthen the areas that patients are weak and make sessions more enjoyable, meaningful and purposeful.

Frequently Asked Questions

How do we know that the child is getting better in their ADHD symptoms and not just memorizing the games?

There is no memorising in CogoLand as the objective of the game is to get the child to focus and sustain their focus. During the game sessions, the attention level of the child is tracked. We monitor the average attention level for each session. Over the whole training course, the child becomes better at their attention control, and we can observe the average attention by session to be trending up.

How will I know if the programme is suitable for my patient and is it a ‘one size fits all’ solution?

CogoLand is designed for children with ADHD who have inattentive symptoms or a combination of inattentive and hyperactive. If the child is predominantly hyperactive, the intervention programme might not be suitable for him/her. CogoLand is a personalised training programme. Before starting the training, the child goes through a ‘Calibration Phase’. This is done under the supervision of a clinician. During Calibration, the child wears Neeuro’s SenzeBand, so his/her EEG data is collected. That data is then used to build the child’s personalised attention state model which is used to track how well the child is focusing during the training sessions.

Can the improvements/changes be seen throughout the rest of the child’s life or does it only have a short effect?

In the latest clinical trial using CogoLand, the intervention programme was done with children at several phases: 8-weeks of intensive training followed by maintenance training (3 sessions per month) over the course of 12 weeks. The researchers saw that Brain-Computer Interface (BCI)-based attention training programme can lessen ADHD symptoms and maintenance training may sustain these improvements.

Could CogoLand replace other treatments available in the market?

CogoLand is not intended to replace other treatment modalities in the market but is intended to be a complementary intervention. A multidisciplinary approach to managing ADHD is ideal. This could include medication, psychological, psycho-social and brain training intervention. While this is so, the reality is the dropout rate for children with ADHD undergoing these various programs can be significant due to factors such as concerns with having children take medicines, encountering side effects, the treatment being too expensive and/or time-consuming.

Medicines change the brain chemistry of the child with ADHD that could allow them to function in an orderly manner. Can BCI-based brain training do the same?

There are many medicines in the market that do manage ADHD symptoms. Often, it’s a question of whether the parent would want their child to take the medication. They are concerned not only with efficacy but also with safety. BCI-based brain training is not just a safe intervention but is also proven effective through the different ADHD assessments but also through brain scans.

Some parents are concerned with children using their gadgets and their screen time effects. Would the CogoLand sessions negatively impact their child’s screen time?

We are very much conscious about concerns over screen time. In CogoLand, the sessions are monitored and limited to 20 minutes. This ensures that we are only using the device to achieve the goal of getting the child to improve and sustain their attention level.

Design a Holistic Plan to Complement your Patients’ ADHD Treatments Today!

Copyright © 2020 NEEURO, PTE LTD. All Rights Reserved.

We are looking for expansion partners in your country!

Looking to integrate our solutions to your company, school or private practice? Contact us and a great partnership awaits! Visit our Business Partnership Opportunities page for more information.

Thank you for submitting the form. Our team will be in contact with you as soon as we can.